High-fiber diet study for solid tumor patients
Part of Cancer, Digestive system clinical trials.
This trial tests whether eating a high-fiber diet can improve your gut health, metabolism, and immune system. It is for people with solid tumors who are able to eat or use a feeding tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have a solid tumor confirmed by biopsy
- You can eat by mouth or through a feeding tube
- Your body mass index (BMI) is at least 18.5
- You are not severely malnourished (nutritional risk score less than 3)
- Your kidney, liver, and blood counts are within certain ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a short-term nutritional supplement combined with health education can improve recovery after surgery for colorectal cancer. It is for people with stage IIa, IIb, or IIIa colon or rectal cancer who have completed surgery and are able to engage in follow-up.
This trial tests whether adding a fiber supplement to standard immunotherapy can help treat advanced non-small cell lung cancer. It's for people whose tumors have high PD-L1 levels and no treatable genetic mutations.
This study tests whether a high-fiber diet program can help people who are about to have a stem cell transplant from a donor. It aims to see if increasing fiber intake during this time is safe and helpful.
This study tests whether eating more whole grains, beans, nuts, and seeds can improve your health. If you live in the UK and are interested in adding these foods to your diet, this trial may be a good fit.
This trial studies whether eating a high-fiber diet can improve how well immunotherapy works against melanoma by affecting gut bacteria. If you have melanoma and are starting or have recently started immunotherapy, this study may be relevant.
This study tests an experimental drug called CT3001 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it's safe and effective, and for some patients with colorectal cancer, it may be combined with standard chemotherapy.
Hear when a new Colorectal Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.